| Date | Title | Description |
| 04.03.2026 | Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026 | 13 oral presentations included, reaffirming the clinical value of AI-based medical image analysis
Highlighting key topics such as early risk stratification based on AI abnormality scores and interval cancer classification
SEOUL, South Korea... |
| 15.12.2025 | Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research | Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research and development programs
SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- Lunit (KRX:328130), a l... |
| 15.12.2025 | Lunit and Daiichi Sankyo Partner to Accelerate Cancer Biomarker Discovery with AI | What You Should Know:
– Lunit has announced a collaboration with pharmaceutical giant Daiichi Sankyo to integrate its AI-powered Lunit SCOPE digital pathology products into two of Daiichi Sankyo’s oncology pipeline programs.
– The partnersh... |
| 08.12.2025 | Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model | Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs
SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer d... |
| 02.12.2025 | Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025 | Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling
SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and pr... |
| 20.11.2025 | Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research | , a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services, announced a collaborative initiative to accelerate innovation in digital pathology (... |
| 17.11.2025 | Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research | DURHAM, N.C. and SEOUL, South Korea, Nov. 17, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services, today announ... |
| 13.11.2025 | CarbonBlack, a Venture Studio Building Physical AI Companies, Appoints former Lunit Co-Founder as Partner | SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- CarbonBlack Inc., a venture studio specializing in founding and scaling companies in the emerging field of Physical AI, today announced the appointment of Minhong Jang, former Co-Founder and Chie... |
| 07.11.2025 | Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025 | Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery
SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ -- Lunit (KRX:328130), a ... |
| 07.11.2025 | Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence | The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name.
SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider... |
| 16.10.2025 | Volpara Earns ACR® Learning Network Vendor Partner Designation | LYNNWOOD, Wash., Oct. 16, 2025 /PRNewswire/ -- Volpara Health has qualified for the American College of Radiology® (ACR®) Learning Network Vendor Partner designation. Volpara Health partnered with one of the latest graduates of the ACR ImPo... |
| 14.10.2025 | Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025 | AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, advanced ccRCC, and NSCLC with data featured in both oral and poster presentations
SEOUL, South Korea, Oct. 14, 2025 /PRNewswire/ -- Lunit (KRX... |
| 24.09.2025 | Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials | SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, today announced a strategic partnership with CellCarta, a globa... |
| 22.09.2025 | Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine | Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a lead... |
| 16.09.2025 | Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025 | Lunit highlights global leadership in cancer AI alongside world health experts with dedicated APEC HLMHE session and WBS 2025 Leaders' Dialogue
SEOUL, South Korea, Sept. 16, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of ... |
| 11.09.2025 | Lunit Awarded Major National Tender in France, Expanding Access to Breast AI in Public Hospitals | Framework agreement with UniHA enables access to Lunit's breast AI solutions across 1,500+ French public hospitals, in collaboration with Fujifilm
SEOUL, South Korea, Sept. 11, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider ... |
| 02.09.2025 | Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program | Milestone European deployment underscores growing global trust in Lunit's AI for population-wide breast cancer screening
SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostic... |
| 02.07.2025 | Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis | SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare sol... |
| 02.06.2025 | BreastScreen Australia Density Reporting Rule is a Critical Step for Women says Volpara Health, the Leader in AI-assisted Breast Density Measurement | Volpara software is used to assess the breast density of more than 1 million Australian women
annually
WELLINGTON, New Zealand, June 2, 2025 /PRNewswire/ -- Volpara Health, a Lunit a company and global leader in software for the early detec... |
| 30.05.2025 | The AI Revolution in Oncology: Lunit's Groundbreaking Advances at ASCO 2025 | The landscape of cancer treatment is shifting. Artificial intelligence (AI) is no longer a futuristic concept; it’s a present-day reality. At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, Lunit showcased how AI is re... |
| 28.05.2025 | Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities | Next-generation AI solution introduces new clinical features and broader disease detection for chest X-rays
SEOUL, South Korea, May 28, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeu... |
| 26.05.2025 | Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies | SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented ... |
| 19.05.2025 | Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition | Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imaging sites
SEOUL, South Korea, May 19, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading ... |
| 07.05.2025 | Lunit to Power Germany's Largest Private Radiology Network with AI Imaging | The five-year framework agreement covers phased rollout of Lunit's AI suite—including chest X-ray, mammography, tomosynthesis, and fracture detection—across 79 Starvision sites
SEOUL, South Korea, May 7, 2025 /PRNewswire/ -- Lunit (KRX:3281... |
| 25.04.2025 | Revolutionizing Breast Cancer Detection: SimonMed and Lunit's Groundbreaking Partnership | In the world of medical imaging, innovation is the lifeblood that fuels progress. Recently, SimonMed Imaging, a titan in outpatient medical imaging, announced a partnership with Lunit, a frontrunner in AI-driven cancer diagnostics. This col... |
| 24.04.2025 | SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection | A Major Leap Forward in Patient Health and the Future of Mammography
PHOENIX, April 24, 2025 /PRNewswire/ -- SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to anno... |
| 23.04.2025 | SimonMed Imaging Partners with Lunit to Deploy AI for Breast Cancer Detection | What You Should Know:
– SimonMed Imaging, one of the largest and most advanced outpatient medical imaging providers in the United States, announced a significant partnership with Lunit, a global leader in AI-driven cancer diagnostics and th... |
| 09.04.2025 | Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening | Despite strong performance from AI, fewer recalls from AI-flagged cases point to challenges in human-AI collaboration
SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for ca... |
| 31.03.2025 | Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research | Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aiming to accelerate personalized cancer care
SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-p... |
| 26.03.2025 | Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca | AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to molecular testing in NSCLC
SEOUL, South Korea, March 26, 2025 /PRNewswi... |
| 19.03.2025 | Shaquille O’Neal Dives into the Ready-to-Drink Cocktail Wave with BeatBox Beverages | Shaquille O’Neal is no stranger to the spotlight. From dominating the basketball court to gracing our screens as an actor and DJ, he has built an empire. Now, he’s stepping into the world of ready-to-drink (RTD) cocktails. His latest ventur... |
| 18.03.2025 | Lunit Secures Multi-Year Contract with UAE's Largest Healthcare Network to Power National AI Breast Cancer Screening Program | Strategic agreement to deploy Lunit INSIGHT MMG across SEHA's extensive healthcare network, analyzing over hundred thousand mammograms over five years
SEOUL, South Korea, March 18, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provi... |
| 11.03.2025 | Lunit's AI Revolution: Transforming Cancer Detection in Saudi Arabia and Beyond | In the world of healthcare, innovation is the lifeblood that keeps the system alive. Lunit, a South Korean company, is injecting that lifeblood into cancer diagnostics with its cutting-edge AI technology. The company is making waves, partic... |
| 10.03.2025 | World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection | Prospective study finds Lunit AI increases cancer detection by 13.8% in single-reader settings without raising recall rates, presenting a game-changing tool for countries relying on single-reader mammography screening
SEOUL, South Korea, Ma... |
| 06.03.2025 | Lunit Expands Partnership with Saudi Arabia's Largest Medical Group to Deploy AI Chest X-Ray Solution | Following last year's success, Lunit secures a second contract with Dr. Sulaiman Al Habib Medical Group, analyzing 1 million chest X-rays over three years
SEOUL, South Korea, March 6, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading pr... |
| 02.03.2025 | Lunit's Bold Moves: Leadership Changes and Groundbreaking AI Research in Cancer Detection | In the fast-paced world of healthcare technology, change is the only constant. Lunit, a South Korean powerhouse in AI-driven cancer diagnostics, is making waves with two significant announcements. The appointment of Craig Hadfield as CEO of... |
| 27.02.2025 | Lunit Achieves Milestone at ECR 2025: 13 Oral Presentations Among 15 AI Studies, Demonstrating Unmatched Clinical Impact | Lunit to present 15 studies, with an unprecedented 13 accepted as oral presentations, marking a significant milestone in AI-powered radiology research
Key studies demonstrate AI's capability to replace one radiologist in double reading, det... |
| 26.02.2025 | Lunit Announces Leadership Transition at Volpara: Craig Hadfield Appointed CEO | SEOUL, South Korea and WELLINGTON, New Zealand, Feb. 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the appointment of Craig Hadfield as th... |
| 05.02.2025 | The Human Cost of Aid Freezes: A Crisis in Al-Hol Camp | In the heart of northeastern Syria lies Al-Hol camp, a place that embodies despair and uncertainty. Here, families linked to the Islamic State (IS) grapple with survival amid a backdrop of shifting political tides and humanitarian crises. T... |
| 03.02.2025 | Lunit Partners with SITC to Launch Exclusive Research Program Featuring Advanced AI Technology for SITC Members | Lunit SCOPE® IO now available to SITC members for AI-powered TME profiling, in a collaborative effort to advance cancer immunotherapy
SEOUL, South Korea, Feb. 3, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered s... |
| 30.01.2025 | ИИ научился предсказывать развитие рака груди за годы до постановки диагноза | Норвежский институт общественного здравоохранения (FHI) сообщил, что искусственный интеллект может определять женщин, у которых повышен риск развития рака молочной железы, за несколько лет до того, как будет поставлен диагноз. Исследователя... |
| 23.01.2025 | Lunit AI Enhances Precision in Predicting Outcomes for HER2-Targeted Therapy in Metastatic Colorectal Cancer - new study published in JCO Precision Oncology | Newly published study in collaboration with Japan's NCCHE reveals how AI-powered HER2 and tumor microenvironment analysis improves patient stratification and clinical outcome predictions
SEOUL, South Korea, Jan. 23, 2025 /PRNewswire/ -- Lun... |
| 12.12.2024 | New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images | Research in npj Precision Oncology highlights multi-cohort training approach and accurate analysis of unseen immunohistochemistry data
SEOUL, South Korea, Dec. 12, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered... |
| 09.12.2024 | Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW | Lunit INSIGHT MMG integrated into the clinical workflow of Australia's BreastScreen New South Wales to assist in reading approximately 31,000 mammography exams annually
SEOUL, South Korea, Dec. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ),... |
| 05.12.2024 | Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care | Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations to transform global cancer care
SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- At this... |
| 02.12.2024 | Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment | Follow-up to ScreenTrustCAD presented at RSNA 2024 highlights 1-year post-AI adoption success in improving cancer detection, radiologist workload, and screening efficiency
SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Lunit (KRX:328130.K... |
| 27.11.2024 | Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging | AI-powered chest X-ray and mammography analysis solutions to be deployed across one of Mexico's largest healthcare networks
SEOUL, South Korea, Nov. 27, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions ... |
| 25.11.2024 | Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts | Twenty studies validate AI performance across diverse populations and clinical settings, including award-winning research in emergency radiology
SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of ... |
| 19.11.2024 | Behavioral change platform Vitality acquires coaching provider WellSpark | Photo: Franziska & Tom Werner/Getty Images
U.K.-based Vitality, which offers tools to promote positive behavioral change in patients, announced its acquisition of U.S.-based coaching platform WellSpark.
WellSpark was formed out of Emble... |
| 18.11.2024 | Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC | Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations
SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-pow... |
| 13.11.2024 | Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network | Agreement to make Lunit INSIGHT MMG accessible to over 400 sites across France
SEOUL, South Korea, Nov. 13, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, toda... |
| 10.11.2024 | The Future of Cancer Care: AI and Yoga Unite for Patient Empowerment | In the realm of cancer care, two distinct yet powerful forces are emerging: artificial intelligence (AI) and yoga. Both are transforming the landscape of treatment and support for patients. As we stand on the brink of a new era in oncology,... |
| 08.11.2024 | Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024 | Study reveals potential of AI-powered tumor microenvironment assessment in predicting treatment outcomes in rare cancer patients receiving pembrolizumab
SEOUL, South Korea, Nov. 8, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provi... |
| 04.11.2024 | Volpara Health Secures $7.3M Contract to Modernize Breast Cancer Screening for U.S. Military | What You Should Know:
– Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
– The contract will deploy Volpara’s Pa... |
| 25.10.2024 | Volpara Health Surpasses 300 Peer-Reviewed Papers | Milestone reinforces leadership in AI-powered breast cancer detection
WELLINGTON, New Zealand, Oct. 25, 2024 /PRNewswire/ -- Volpara Health, a Lunit company and global leader in artificial intelligence (AI)-powered breast health solutions, ... |
| 24.10.2024 | Bridging the Gap: The Urgent Need for Comprehensive Glaucoma Research in the U.S. | In the vast landscape of American healthcare, some conditions slip through the cracks. Glaucoma is one of them. A silent thief, it steals vision without warning. Dr. Rohit Varma, a leading figure in ophthalmology, has shed light on this iss... |
| 23.10.2024 | Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance | Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving screening quality, and predicts cancer risk up to six years in advance
SEOUL, South Korea, Oct. 23, 2024 ... |
| 10.09.2024 | Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024 | Lunit SCOPE IO® demonstrates potential to assess immune phenotype as an AI-powered biomarker for predicting efficacy of Nivolumab plus Chemotherapy in advanced gastric cancer, independent of PD-L1 status
SEOUL, South Korea, Sept. 10, 2024 /... |
| 09.09.2024 | Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing | Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing
SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit (KRX:... |
| 06.09.2024 | The New Frontier in Cancer Treatment: AI and Immune Phenotyping | In the battle against cancer, every tool counts. The latest weapon in this fight? Artificial intelligence. A recent study highlights the potential of Lunit SCOPE IO®, an AI-driven platform that analyzes the tumor microenvironment in biliary... |
| 03.09.2024 | Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR | AI-based tumor microenvironment classification utilizing Lunit SCOPE IO® shows promise for guiding treatment decisions in advanced BTC
SEOUL, South Korea, Sept. 3, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered... |
| 06.08.2024 | Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study | Lancet Digital Health study highlights Lunit INSIGHT CXR as top performer in TB screening, showing promise for improving detection in high-burden settings
SEOUL, South Korea, Aug. 6, 2024 /PRNewswire/ -- Lunit, a leading provider of AI-powe... |
| 22.07.2024 | Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program | Middle East's first full-scale AI adoption for national screening marks Lunit's latest milestone amid rapid expansion of global cancer screening initiatives
SEOUL, South Korea, July 22, 2024 /PRNewswire/ -- Lunit, a leading provider of AI-p... |
| 01.07.2024 | Transforming Healthcare with AI: YiduTech's Gong Rujing at Summer Davos | DALIAN, China, July 1, 2024 /PRNewswire/ -- "AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcar... |
| 30.06.2024 | Transforming Healthcare with AI: YiduTech's Gong Rujing at Summer Davos | DALIAN, China, June 30, 2024 /PRNewswire/ -- "AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthca... |
| 24.05.2024 | Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response | - Lunit's ASCO 2024 presentations to highlight advances including HER2 ultra-low detection and AI-powered ICI response prediction models for NSCLC, demonstrating the impact of Lunit SCOPE suite on precision oncology
SEOUL, South Korea, May ... |
| 22.05.2024 | Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care | SEOUL, South Korea, May 22, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proudly announces the successful completion of its acquisition of Volpara Health Tec... |
| 20.05.2024 | Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite | - From research to real-world impact: Lunit demonstrates Lunit INSIGHT's clinical safety, effectiveness, and efficiency in 100 papers
SEOUL, South Korea, May 20, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered s... |
| 08.04.2024 | Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals | - Employing Lunit INSIGHT MMG, a Turkish study showcases 70% efficiency improvements, advancements in early cancer detection, and interval cancer detection in mammography
SEOUL, South Korea, April 8, 2024 /PRNewswire/ -- Lunit (KRX:328130.K... |
| 01.04.2024 | Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification | - Lunit's AACR 2024 presentations to spotlight HER2 mutation insights and CNTN4's role in immunotherapy success, pioneering next-gen personalized treatment approaches, supported by the AI-powered Lunit SCOPE suite
SEOUL, South Korea, April ... |
| 26.03.2024 | Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients | - New research published in Clinical Cancer Research shows significant improvement in distant recurrence-free survival with combined durvalumab and tremelimumab treatment, supported by Lunit SCOPE IO's analysis of tumor microenvironment
SEO... |
| 20.03.2024 | New AI Tool Designed to Predict Patients' Breast Cancer Side Effect Tendencies | Aldohn Domingo, Tech Times 20 March 2024, 10:03 pm
Doctors continue to progress medical technology using artificial intelligence (AI) as a new tool, dubbed the Pre-Act Project, which has reportedly been designed to predict cancer patients' ... |
| 18.03.2024 | Lunit Expands AI-powered Cancer Screening Solution to France and Portugal | What You Should Know:
– Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion.
– These strategic deals... |
| 18.03.2024 | Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal | New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League Against Cancer
SEOUL, South Korea, March 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a lead... |
| 14.03.2024 | Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research | - Lunit SCOPE HER2 and Lunit SCOPE ER/PR significantly improve pathologist concordance and accuracy, paving the way for improved breast cancer molecular subtype analysis for informed decision-making and precision patient care
SEOUL, South K... |
| 13.03.2024 | Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured | - Volpara shareholder meeting to be held on April 12, 2024: Culminating the acquisition journey for Lunit, finalization set for May
SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered s... |
| 28.02.2024 | Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings | - Lunit to unveil four oral presentations and three poster presentations at ECR 2024, highlighting Lunit INSIGHT's expansive capability, ranging from adaptability in different use cases to the potential to replace a human reader in mammogra... |
| 16.02.2024 | New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC | - A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint... |
| 17.01.2024 | Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology | - Lunit's AI-powered chest X-ray analysis solution shows highest AUC of 0.93 in a recent multi-center, multi-use case, multi-vendor lung nodule detection study
SEOUL, South Korea, Jan. 17, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leadi... |
| 17.01.2024 | Lunit AI Solutions to Power Samsung’s X-ray Devices for Advanced Chest Screening | Three-year supply contract: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to enhance lung abnormality detection in Samsung’s premium X-ray devices
Lunit , a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, ... |
| 16.01.2024 | Lunit and Samsung Integrate to Power AI-Powered Chest Screenings | What You Should Know:
– Lunit, an innovator in AI-powered cancer diagnostics, and Samsung Electronics (Samsung Healthcare) have announced a groundbreaking three-year supply contract.
– The strategic partnership integrates Lunit’s cutting-ed... |
| 16.01.2024 | Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening | Three-year supply contract: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to enhance lung abnormality detection in Samsung's premium X-ray devices
SEOUL, South Korea, Jan. 16, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider ... |
| 19.12.2023 | Deals in brief: Shopee buys credit arm of Brazil’s Blu, Biorithm and Blue Planet secure funding, multiple China and India deals, and more | Shopee buys Blu’s local credit arm to expand footprint in Brazil
Shopee, one of the leading e-commerce companies in Southeast Asia, has bought the local credit arm of Blu, a Brazilian fintech company, according to The Business Times.
The de... |
| 15.12.2023 | Deals in brief: Rose All Day Cosmetics confirms Series A funding, Velocity Ventures invests in Joyned, Lunit to acquire Volpara, and more | Rose All Day Cosmetics confirms completion of Series A round
Following reports on December 8 regarding Rose All Day Cosmetics (RADC)’s forthcoming completion of its Series A funding round, the Indonesian D2C cosmetics brand has officially c... |
| 11.12.2023 | Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project | After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation in Australia's BreastScreen NSW Machine Reading Solution Project
SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI... |
| 01.12.2023 | Lunit to Advance Singapore’s Healthcare System with AI-powered Solution for Medical Imaging | Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General Hospital through AimSG, a national medical imaging AI platform for Singapore’s Public Healthcare
Lunit, a leading provider of AI-powered solutions for cancer diag... |
| 30.11.2023 | Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging | Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General Hospital through AimSG, a national medical imaging AI platform for Singapore's Public Healthcare
SEOUL, South Korea, Nov. 30, 2023 /PRNewswire/ -- Lunit (KRX:3281... |
| 29.11.2023 | AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer – published in npj Precision Oncology | Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, published a new study in npj Precision Oncology (Nature Partner Journal), using Lunit SCOPE IO to predict prognosis in stage II–III colon cancer via A... |
| 27.11.2023 | AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology | AI-powered spatial analysis of tumor-infiltrating lymphocytes using Lunit SCOPE IO provides accurate prognosis prediction in stage II–III colon cancer
SEOUL, South Korea, Nov. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provid... |
| 22.11.2023 | Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology | - A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with that of radiologists in detecting breast cancer
SEOUL, South Korea, Nov. 22, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a ... |
| 16.11.2023 | Lunit receives $150M capital chip-in, doubles down on US market | Photo courtesy of Lunit |
| 16.11.2023 | Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals | - Lunit brings Lunit INSIGHT CXR to five major Saudi hospitals, aiming to enhance early detection of common lung abnormalities and improve patient outcomes in line with the national health strategy
SEOUL, South Korea, Nov. 16, 2023 /PRNewsw... |
| 15.11.2023 | Lunit Secures $150 Million in Capital Increase | Fund fully paid-in as of November 9, achieving over 100% shareholder participation
SEOUL, South Korea, Nov. 15, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, ... |
| 14.11.2023 | Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT | - Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market
SEOUL, South Korea, Nov. 14, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and... |
| 13.11.2023 | Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care | - Lunit INSIGHT suite, Lunit's AI-driven solutions for early detection of cancer, featured in CancerX's first official project: enhancing equity and reducing financial burden in cancer care
SEOUL, South Korea, Nov. 13, 2023 /PRNewswire/ -- ... |
| 06.11.2023 | Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023 | Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment
SEOUL, South Korea, Nov. 6, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a ... |
| 06.11.2023 | Lunit Joins as an Associate Partner with the World Economic Forum | Lunit joins as an Associate Partner of the World Economic Forum, propelling global expansion and collaboration in the realm of AI-driven cancer care
Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, h... |
| 01.11.2023 | AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023 | Six posters featuring the Lunit SCOPE suite and new insights into the tumor microenvironment are to be showcased at the SITC 2023 Annual Meeting
SEOUL, South Korea, Nov. 1, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of A... |
| 31.10.2023 | Lunit Joins as an Associate Partner with the World Economic Forum | - Lunit joins as an Associate Partner of the World Economic Forum, propelling global expansion and collaboration in the realm of AI-driven cancer care
SEOUL, South Korea, Oct. 31, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provid... |
| 27.10.2023 | Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy | - Lunit to support MD Anderson researchers studying immune phenotype biomarkers for pembrolizumab treatment response
SEOUL, South Korea, Oct. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for can... |
